Griffith SN, Stapleton E, Padilla S et al. Physical compatibility of milrinone 1 mg/mL with select cardiovascular medications during simulated Y-site administration. Am J Health Syst Pharm. 2020; 77:1938-1940.[PubMed 32991671]